46 science "https:" "https:" "https:" "https:" "https:" Fellowship positions at Northeastern University
Sort by
Refine Your Search
-
Alnylam We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has
-
, and scholarly activities. In partnership with Northeastern University, Dompé is offering a two-year fellowship in Global Medical Affairs - Real-World Evidence & Health Economics and Outcomes Research
-
facility in Kendall Square. About AstraZeneca At AstraZeneca, we’re dedicated to being a Great Place to Work, where you’re empowered to push the boundaries of science and unleash your entrepreneurial spirit
-
. About GSK GSK is a focused biopharma company with strong momentum and big ambitions, to unite science, technology, and talent to get ahead of disease together. We aim to positively impact the health
-
also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including IgA nephropathy
-
, and scholarly activities. In partnership with Northeastern University, Vertex Pharmaceutical is offering a two-year Clinical Science fellowship, based in Boston, Massachusetts. About Vertex Vertex is a
-
to clinical research, health economics and outcomes research, and real-world evidence. The Fellow will support strategic dissemination of data across a wide range of channels and lead diverse projects
-
, including IgA nephropathy, neuropathic pain, APOL1-mediated kidney disease, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, and myotonic dystrophy type 1. Vertex
-
clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including IgA nephropathy, neuropathic pain, APOL1
-
prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA